Introduction: Revolutionary changes in the macrolide and azalide antibiotics
- 12 September 1991
- journal article
- editorial
- Published by Elsevier in The American Journal of Medicine
- Vol. 91 (3) , S1-S4
- https://doi.org/10.1016/0002-9343(91)90393-c
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Multiple mechanisms of erythromycin resistanceJournal of Antimicrobial Chemotherapy, 1990
- Intracellular accumulation of azithromycin by cultured human fibroblastsAntimicrobial Agents and Chemotherapy, 1990
- The pharmacokinetics of azithromycin in human serum and tissuesJournal of Antimicrobial Chemotherapy, 1990
- New directions for macrolide antibiotics: pharmacokinetics and clinical efficacyAntimicrobial Agents and Chemotherapy, 1989
- New directions for macrolide antibiotics: structural modifications and in vitro activityAntimicrobial Agents and Chemotherapy, 1989
- Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growthAntimicrobial Agents and Chemotherapy, 1989
- Plasmid-mediated high-level resistance to erythromycin in Escherichia coliAntimicrobial Agents and Chemotherapy, 1986
- Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: The resistance phenotype, its biological diversity, and structural elements that regulate expression - A reviewJournal of Antimicrobial Chemotherapy, 1985